Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:224 Flecainide
Search Links: General Info : Protocols : Patient Info

DescriptionCardiac anti-arrhythmic drug. Acts by blocking fast sodium channels. For monitoring purposes, blood should not be drawn until a steady state has been attained.
IndicationTherapeutic drug monitoring (TDM) of anti-arrhythmic drugs
Additional InfoUsed for treatment of AV nodal reciprocating tachycardia. Normal dose in adults is 200-400 mg/day. Excreted unchanged in urine.
Concurrent Tests
Dietary Requirements

InterpretationHalf life is 14 hours, 20 hours if have ventricular arrhythmias. Steady state plasma levels achieved after 3-5 days of treatment.

Ref. Range (Male)0.15 - 0.9
Ref. Range (Female)0.15 - 0.9
Ref. Range (Paed)
Ref. Range Notes

IP Acute TAT- Not Defined -
IP Routine TAT- Not Defined -
GP Acute TAT- Not Defined -
GP Routine TAT- Not Defined -
Turnround CommentTurnaround time stated by referral lab: 7 days
Originally edited by : JHB. Last edited on 22/07/2020 14:08:39. Published By Eleanor McLaughlan on 22/07/2019 14:08:39.